SOX17 drives resilience of the arterial endothelium under shear stress
This study identifies SOX17 as a critical shear-stress-induced regulator of arterial endothelial barrier integrity and resilience, demonstrating that its deficiency impairs junctional stability and promotes vascular injury through the downregulation of the downstream effector SEMA3G.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inside the human body, blood does not merely sit still; it rushes through a vast network of tubes, constantly rubbing against the inner walls of the arteries. This rubbing force, known as shear stress, is a powerful physical signal that the cells lining these vessels must understand and respond to. When blood flows smoothly in a single direction, it tells the cells to stay healthy, aligned, and tightly joined together, forming a seamless barrier that keeps blood where it belongs and prevents harmful substances from leaking into surrounding tissues. However, when this flow becomes turbulent or the cells lose their ability to sense the force, the barrier can break down. This failure is at the heart of many serious vascular diseases, including pulmonary arterial hypertension, a condition where the blood vessels in the lungs become damaged and stiff, leading to heart failure. For years, scientists have known that a specific protein called SOX17 is vital for building arteries during embryonic development, but its role in the adult body, particularly in how it helps cells withstand the constant friction of flowing blood, remained a mystery.
A team of researchers set out to solve this puzzle by studying human lung cells in the laboratory. They wanted to see what happens when these cells are exposed to the same forces they feel inside a living body. Using a specialized system that pumps fluid over the cells to mimic the pressure of blood flow, they discovered that SOX17 is not just a builder of arteries, but a guardian of their strength. When the cells were subjected to a strong, steady flow of fluid, similar to what is found in large lung arteries, the amount of SOX17 inside them increased significantly. This increase was a direct response to the physical force of the flow, suggesting that the protein is a key part of the cell's defense mechanism against the stress of moving blood.
The researchers then tested what would happen if they removed SOX17 from these cells. Without this protein, the cells struggled to adapt. When exposed to the same flowing fluid, they failed to stretch out and align properly with the direction of the flow. More critically, the tight seals between the cells began to fail. Gaps appeared between them, allowing the barrier to break down. In a healthy vessel, the cells hold on to each other with strong molecular hands, but without SOX17, these hands let go. The cells also lost their ability to repair themselves quickly when damaged, and they stopped dividing as they should to replace lost tissue. The study showed that this breakdown was not just a minor glitch; under the pressure of flowing fluid, the cells without SOX17 fell apart much faster than healthy ones, creating large holes in the protective lining.
To understand how SOX17 works, the scientists looked at the genetic instructions inside the cells. They found that SOX17 acts like a switch that turns on the production of specific proteins needed to keep the cells stuck together. It directly activates genes that build the molecular "glue" holding the cells in place. Furthermore, the researchers discovered that SOX17 also triggers the production of another protein called SEMA3G. This second protein acts as a messenger that helps stabilize the connections between cells. When the researchers added extra SEMA3G to the cells that were missing SOX17, it partially fixed the problem. The gaps between the cells shrank, and the molecular glue returned, proving that SEMA3G is a crucial part of the repair team that SOX17 calls upon.
The study went beyond flat layers of cells to test these findings in a more realistic model. The team built tiny, three-dimensional blood vessels inside a microchip, creating a miniature version of a human artery. Even in this complex, three-dimensional environment, the results held true. Cells without SOX17 could not maintain the shape of the vessel or the integrity of the wall under flow, while adding the SEMA3G protein helped restore the structure. The researchers also confirmed that SOX17 binds directly to the genetic regions that control these protective proteins, proving that it is the master regulator of this survival program.
This work reveals that SOX17 is essential for the resilience of the arterial lining. It is the mechanism that allows the blood vessel wall to sense the force of the blood and strengthen itself in response. When this system fails, as it might in people with certain genetic variations that lower SOX17 levels, the vessel becomes vulnerable to injury and leakage. The findings suggest that the damage seen in diseases like pulmonary arterial hypertension may stem from this inability to adapt to the physical forces of blood flow. By identifying SOX17 and its partner SEMA3G as the key players in this process, the study points toward new ways to protect the blood vessels, potentially by boosting these natural defense mechanisms to keep the arterial barrier strong and intact.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.